Galmed downgraded to Hold from Buy at Maxim
Maxim analyst Naz Rahman downgraded Galmed (GLMD) to Hold from Buy.Don't Miss Our End of Quarter Offers: Discover the latest stocks recommended ...
Maxim Group Sticks to Their Buy Rating for Palisade Bio (PALI)
Maxim Group analyst Naz Rahman reiterated a Buy rating on Palisade Bio (PALI – Research Report) yesterday. The company’s shares opened today at ...
TipRanks on MSN19d
scPharmaceuticals price target lowered to $12 from $20 at Maxim
Maxim analyst Naz Rahman lowered the firm’s price target on scPharmaceuticals (SCPH) to $12 from $20 but keeps a Buy rating on the shares after ...